PL1948131T6 - Farmaceutyczna kompozycja, wolna od dekspantenolu, jonów wapnia i fosforanów, oraz zastosowanie wapniowego środka chelatotwórczego i oftalmologicznie zgodnego regulatora lepkości - Google Patents

Farmaceutyczna kompozycja, wolna od dekspantenolu, jonów wapnia i fosforanów, oraz zastosowanie wapniowego środka chelatotwórczego i oftalmologicznie zgodnego regulatora lepkości

Info

Publication number: PL1948131T6
Authority: PL; Poland
Prior art keywords: phosphate; calcium; pharmaceutical composition; chelating agent; dexpanthenol
Prior art date: 2005-11-17

Application number

PL06818627T

Other languages

English (en)

Other versions

PL1948131T3 (pl

Inventor

Frank Holzer

Dorothea Gross

Original Assignee

Ursapharm Arzneimittel Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-17

Filing date

2006-11-17

Publication date

2013-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37989463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1948131(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-11-17 Application filed by Ursapharm Arzneimittel Gmbh filed Critical Ursapharm Arzneimittel Gmbh

2009-08-31 Publication of PL1948131T3 publication Critical patent/PL1948131T3/pl

2013-09-30 Publication of PL1948131T6 publication Critical patent/PL1948131T6/pl

Links

239000003715 calcium chelating agent Substances 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 3
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 title abstract 2
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 title abstract 2
235000004866 D-panthenol Nutrition 0.000 title abstract 2
239000011703 D-panthenol Substances 0.000 title abstract 2
229910001424 calcium ion Inorganic materials 0.000 title abstract 2
229910000389 calcium phosphate Inorganic materials 0.000 title abstract 2
229960003949 dexpanthenol Drugs 0.000 title abstract 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title abstract 2
239000010452 phosphate Substances 0.000 title abstract 2
230000007547 defect Effects 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Pulmonology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Detergent Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL06818627T 2005-11-17 2006-11-17 Farmaceutyczna kompozycja, wolna od dekspantenolu, jonów wapnia i fosforanów, oraz zastosowanie wapniowego środka chelatotwórczego i oftalmologicznie zgodnego regulatora lepkości PL1948131T6 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102005055275A DE102005055275A1 (de)	2005-11-17	2005-11-17	Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
EP06818627A EP1948131B3 (de)	2005-11-17	2006-11-17	Dexpanthenol-, calciumionen- und phosphatfreie pharmazeutische zusammensetzung sowie verwendung von calcium-chelatbildner und ophthalmologisch verträglichem viskositätsregler
PCT/EP2006/011053 WO2007057201A2 (de)	2005-11-17	2006-11-17	Dexpanthenol-, calciumionen- und phosphatfreie pharmazeutische zusammensetzung sowie verwendung von calcium-chelatbildner und ophthalmologisch verträglichem viskositätsregler

Publications (2)

Publication Number	Publication Date
PL1948131T3 PL1948131T3 (pl)	2009-08-31
PL1948131T6 true PL1948131T6 (pl)	2013-09-30

Family

ID=37989463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06818627T PL1948131T6 (pl)	2005-11-17	2006-11-17	Farmaceutyczna kompozycja, wolna od dekspantenolu, jonów wapnia i fosforanów, oraz zastosowanie wapniowego środka chelatotwórczego i oftalmologicznie zgodnego regulatora lepkości

Country Status (14)

Country	Link
US (1)	US8648057B2 (pl)
EP (1)	EP1948131B3 (pl)
JP (1)	JP2009515921A (pl)
CN (1)	CN101312711B (pl)
AT (1)	ATE425742T1 (pl)
CA (1)	CA2630193C (pl)
CY (1)	CY1109112T1 (pl)
DE (2)	DE102005055275A1 (pl)
DK (1)	DK1948131T3 (pl)
ES (1)	ES2324118T7 (pl)
PL (1)	PL1948131T6 (pl)
PT (1)	PT1948131E (pl)
SI (1)	SI1948131T1 (pl)
WO (1)	WO2007057201A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITPD20070208A1 (it) *	2007-06-19	2008-12-20	Alessandro Filippo	Metodo di umidificazione di una lente a contatto
US9566256B2 (en)	2008-09-22	2017-02-14	Biochemics, Inc.	Transdermal drug delivery using an osmolyte and vasoactive agent
DE102009021372A1 (de)	2009-05-14	2010-11-18	Ursapharm Arzneimittel Gmbh	Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
AT511164A1 (de)	2011-03-03	2012-09-15	Croma Pharma Gmbh	Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
ES2837626T3 (es)	2013-07-10	2021-07-01	Matrix Biology Inst	Composiciones de hialuronano con alta elasticidad y usos de las mismas
FR3019465B1 (fr)	2014-04-02	2017-06-23	Horus Pharma	Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
ES2871199T3 (es) *	2015-09-24	2021-10-28	Matrix Biology Inst	Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
ITUB20160543A1 (it) *	2016-02-08	2017-08-08	Sooft Italia S P A 63833 Montegiorgio Fermo / Italia	Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali
JP7258778B2 (ja)	2017-03-05	2023-04-17	レスデブコリサーチアンドディベロップメントカンパニーリミテッド	感染によるものではない刺激の治療のための点眼剤
US11766421B2 (en)	2017-09-25	2023-09-26	Surface Ophthalmics, Inc.	Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP3781175A1 (en) *	2018-04-18	2021-02-24	i.com Medical GmbH	High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
BR112021000863A2 (pt) *	2018-05-01	2021-04-13	Jinan Cao	Colírios que curam cataratas, presbiopia e
JP2020075918A (ja) *	2018-11-02	2020-05-21	千寿製薬株式会社	角膜上皮創傷治癒促進用の眼科用組成物
RU2679319C1 (ru) *	2018-11-27	2019-02-07	Илья Александрович Марков	Гелеобразная искусственная слеза с антисептическим и репаративным действием
KR20210141448A (ko)	2018-12-27	2021-11-23	서피스 아프샐믹스 인코포레이티드	안구 표면 질환을 치료하기 위한 안과용 약학 조성물 및 방법
US12268706B2 (en)	2019-01-31	2025-04-08	i.com medical GmbH	Hyaluronic acid for relief of idiopathic ocular pain
US12440510B2 (en)	2021-05-10	2025-10-14	Surface Ophthalmics, Inc.	Use of chondroitin sulfate for relieving ocular pain
US12310981B2 (en)	2021-05-10	2025-05-27	Surface Ophthalmics, Inc.	Use of chondroitin sulfate for relieving ocular pain

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4409205A (en) *	1979-03-05	1983-10-11	Cooper Laboratories, Inc.	Ophthalmic solution
EP0145710A1 (en) *	1983-05-25	1985-06-26	Alcon Laboratories, Inc.	Ophthalmic solution
US4629623A (en)	1984-06-11	1986-12-16	Biomatrix, Inc.	Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof
US5705485A (en) *	1987-09-18	1998-01-06	Ethicon, Inc.	Gel formulations containing growth factors
JPH075456B2 (ja) *	1988-10-01	1995-01-25	参天製薬株式会社	点眼液
US6271216B1 (en) *	1989-07-24	2001-08-07	Allergan	Stable solution of hyaluronate in a balanced salt medium
DE69017559T3 (de) *	1989-07-24	2002-06-06	Allergan Pharmaceuticals (Ireland) Ltd., Irvine	Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu.
EP0464727B1 (en) *	1990-06-29	1996-01-03	Santen Pharmaceutical Co., Ltd.	Use of a composition for the preparation of a medicament for debridment of retained lens material
JPH0748262A (ja) *	1993-06-04	1995-02-21	Senju Pharmaceut Co Ltd	外眼部投与用組成物
IT1273011B (it)	1994-07-25	1997-07-01	Trhecnopharma S A	Preparato oftalmico per l'uso come lacrima artificiale
DE19729879C2 (de) *	1997-07-11	1999-07-08	Mann Gerhard Chem Pharm Fab	Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
AU2001285006A1 (en) *	2000-08-21	2002-03-04	Bausch And Lomb Surgical, Inc.	Prevention of posterior capsular opacification by endocapsular circulation of chemical agents
AU2002228449B2 (en) *	2001-01-09	2007-12-06	Louis Johan Wagenaar	Procedure and composition of treatment and/or care of the eye
JP2003002837A (ja) *	2001-06-21	2003-01-08	Lion Corp	水性外用剤組成物及び液体組成物の白濁防止方法
DE10161149B4 (de) *	2001-12-12	2007-03-08	Ursapharm Arzneimittel Gmbh & Co. Kg	Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) *	2001-12-12	2003-06-26	Ursapharm Arzneimittel Gmbh	Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
JP2003206241A (ja) *	2002-01-11	2003-07-22	Teika Seiyaku Kk	眼科用剤
JP4263456B2 (ja)	2002-03-18	2009-05-13	わかもと製薬株式会社	ヒアルロン酸含有熱ゲル化製剤
JP2004059432A (ja)	2002-06-04	2004-02-26	Rohto Pharmaceut Co Ltd	角膜障害治療剤
WO2004039403A1 (ja) *	2002-10-31	2004-05-13	Senju Pharmaceutical Co., Ltd.	角膜障害治療剤
GB0225518D0 (en)	2002-11-01	2002-12-11	Airbus Uk Ltd	Welding method
US7083803B2 (en) *	2003-09-19	2006-08-01	Advanced Ocular Systems Limited	Ocular solutions
JP4947977B2 (ja) *	2003-10-31	2012-06-06	わかもと製薬株式会社	可逆性熱ゲル化水性組成物
JP2005239622A (ja)	2004-02-26	2005-09-08	Rohto Pharmaceut Co Ltd	角膜障害治療剤
JPWO2005102375A1 (ja)	2004-04-23	2008-03-06	千寿製薬株式会社	Ｐａｃａｐおよびその誘導体を含有する角膜神経突起形成促進剤
US8569367B2 (en) *	2004-11-16	2013-10-29	Allergan, Inc.	Ophthalmic compositions and methods for treating eyes

2005
- 2005-11-17 DE DE102005055275A patent/DE102005055275A1/de not_active Ceased
2006
- 2006-11-17 WO PCT/EP2006/011053 patent/WO2007057201A2/de not_active Ceased
- 2006-11-17 US US12/084,803 patent/US8648057B2/en active Active
- 2006-11-17 ES ES06818627T patent/ES2324118T7/es active Active
- 2006-11-17 DE DE502006003215T patent/DE502006003215D1/de active Active
- 2006-11-17 CN CN200680043135XA patent/CN101312711B/zh active Active
- 2006-11-17 EP EP06818627A patent/EP1948131B3/de active Active
- 2006-11-17 AT AT06818627T patent/ATE425742T1/de active
- 2006-11-17 PT PT06818627T patent/PT1948131E/pt unknown
- 2006-11-17 PL PL06818627T patent/PL1948131T6/pl unknown
- 2006-11-17 DK DK06818627T patent/DK1948131T3/da active
- 2006-11-17 CA CA2630193A patent/CA2630193C/en active Active
- 2006-11-17 JP JP2008540522A patent/JP2009515921A/ja active Pending
- 2006-11-17 SI SI200630310T patent/SI1948131T1/sl unknown
2009
- 2009-05-28 CY CY20091100567T patent/CY1109112T1/el unknown

Also Published As

Publication number	Publication date
CN101312711B (zh)	2013-07-17
ES2324118T3 (es)	2009-07-30
DE502006003215D1 (de)	2009-04-30
WO2007057201A3 (de)	2007-08-02
CA2630193C (en)	2015-05-19
US20090111770A1 (en)	2009-04-30
PL1948131T3 (pl)	2009-08-31
US8648057B2 (en)	2014-02-11
EP1948131A2 (de)	2008-07-30
ES2324118T7 (es)	2013-07-30
WO2007057201A2 (de)	2007-05-24
DE102005055275A1 (de)	2007-05-24
HK1125027A1 (zh)	2009-07-31
EP1948131B3 (de)	2013-03-27
CN101312711A (zh)	2008-11-26
EP1948131B1 (de)	2009-03-18
SI1948131T1 (sl)	2009-08-31
JP2009515921A (ja)	2009-04-16
ATE425742T1 (de)	2009-04-15
CY1109112T1 (el)	2014-07-02
PT1948131E (pt)	2009-06-12
CA2630193A1 (en)	2007-05-24
DK1948131T3 (da)	2009-07-13

Publication	Publication Date	Title
CY1109112T1 (el)	2014-07-02	Ελευθερη απο ιοντα δεξπανθενολης, ασβεστιου και φωσφορικο φαρμακευτικη συνθεση καθως και χρησιμοποιηση παραγοντων σχηματισμου χηλικων ενωσεων ασβεστιου και οφθαλμολογικα υποφερτου ρυθμιστη ιξωδους
PT1984357E (pt)	2013-12-23	Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
UA86599C2 (en)	2009-05-12	Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
TNSN07005A1 (fr)	2008-06-02	Analogues tetrapeptidiques
MX2010004319A (es)	2010-04-30	Compuesto de alfa-(n-sulfonamido)acetamida novedoso como un inhibidor de producccion de peptido beta amiloide.
UA95644C2 (ru)	2011-08-25	Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
MX2007015863A (es)	2008-04-02	Inhibidores de esfingosina cinasa.
TW200716201A (en)	2007-05-01	Ophthalmic devices for sustained delivery of active compounds
PL1999160T3 (pl)	2010-06-30	Akrylowany kwas hialuronowy
TNSN08370A1 (en)	2009-12-29	Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2024014480A (es)	2025-01-09	Composiciones farmaceuticas acuosas que comprenden inhibidores de sglt-2
MX2009003763A (es)	2009-04-22	Inhibidores de metaloproteasa derivados de heterociclicos.
TW200732296A (en)	2007-09-01	Novel compounds
EA200970377A1 (ru)	2009-10-30	Композиции фенилалкиламинокарбамата
MX2007014172A (es)	2008-04-02	Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
MX2009003981A (es)	2009-04-27	Agentes moduladores del receptor de calcio.
MY149606A (en)	2013-09-13	Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
MXPA05009712A (es)	2005-10-18	Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales.
MX2019011506A (es)	2019-11-01	Inhibicion de cinasa 1 de punto de control (chk1) para el tratamiento de cancer.
TW200734344A (en)	2007-09-16	Antibacterial agents
EA200701820A1 (ru)	2008-02-28	Применение диосметиновых соединений при лечении и профилактике тромботических патологий
TW200504402A (en)	2005-02-01	Antimicrobial lenses, processes to prepare them and methods of their use
MX2007001953A (es)	2007-05-09	Enantiomeros de pirimidonas fusionadas seleccionadas y usos en el tratamiento y prevencion del cancer.
MY147271A (en)	2012-11-30	Accelerating agent of calcium absorption
WO2008065485A3 (en)	2009-04-23	Stable pharmaceutical compositions of a calcium channel blocker and an ace inhibitor